Data as of 11:07am ET
| +0.07 / +0.09%|
The 16 analysts offering 12-month price forecasts for Cubist Pharmaceuticals Inc have a median target of 83.50, with a high estimate of 97.00 and a low estimate of 63.00. The median estimate represents a +11.29% increase from the last price of 75.03.
The current consensus among 20 polled investment analysts is to Buy stock in Cubist Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.